L&G Healthcare Breakthrough UCITS ETF USD Accumulating ETF/  IE00BK5BC677  /

Fonds
NAV2024. 06. 07. Vált.-0,1073 Hozam típusa Investment Focus Alapkezelő
11,4849USD -0,93% Újrabefektetés Részvény Világszerte LGIM Managers (EU) 

Befektetési stratégia

The Fund is a passively managed exchange traded Fund that is a passively managed exchange traded Fund ("ETF") that aims to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the "Index"), subject to the deduction of the ongoing charges and other costs associated with operating the Fund.The Fund has a sustainable investment objective as it invests in companies which (i) contribute to social objectives, (ii) do not significantly harm any environmental or social objectives, and (iii) follow good governance practices. Shares in this Share Class (the "Shares") are denominated in USD and can be bought and sold on stock exchanges by ordinary investors using an intermediary (e.g. a stockbroker). In normal circumstances, only Authorised Participants may buy and sell Shares directly with the Company. Authorised Participants may redeem their Shares on demand in accordance with the "Dealing Timetable" published on http://www.lgim.com.The Index is comprised of companies which are publically traded on various stock exchanges around the world that generate a proportion of their revenues from the healthcare technology industry. The industry is deemed to be comprised of the following nine subsectors: diagnostic, lab process automation, genomics, regenerative medicine, precision medicine, telehealth, data analytics, robotics and medical instruments. A company is only eligible for inclusion in the Index if it is of a sufficient size (determined by reference to the total market value of its shares) and it is sufficiently "liquid" (a measure of how actively its shares are traded on a daily basis).
 

Befektetési cél

The Fund is a passively managed exchange traded Fund that is a passively managed exchange traded Fund ("ETF") that aims to track the performance of the ROBO Global® Healthcare Technology and Innovation Index TR (the "Index"), subject to the deduction of the ongoing charges and other costs associated with operating the Fund.The Fund has a sustainable investment objective as it invests in companies which (i) contribute to social objectives, (ii) do not significantly harm any environmental or social objectives, and (iii) follow good governance practices.
 

Törzsadatok

Hozam típusa: Újrabefektetés
Alapok Kategória: Részvény
Régió: Világszerte
Ágazat: ETF Stocks
Benchmark: ROBO Global® Healthcare Technology and Innovation Index
Üzleti év kezdete: 07. 01.
Last Distribution: -
Letétkezelő bank: The Bank of New York Mellon SA/NV
Származási hely: Írország
Elosztás engedélyezése: Ausztria, Németország, Svájc
Alapkezelő menedzser: -
Alap forgalma: 71,42 mill.  USD
Indítás dátuma: 2019. 06. 17.
Befektetési fókusz: -

Feltételek

Kibocsátási felár: 0,00%
Max. Administration Fee: 0,49%
Minimum befektetés: 1,00 USD
Deposit fees: -
Visszaváltási díj: 0,00%
Egyszerűsített tájékoztató: Letöltés (Nyomtatási változat)
 

Alapkezelő

Alapkezelő cégek: LGIM Managers (EU)
Cím: 2 Dublin Landings, 1-W-131, Dublin
Ország: Írország
Internet: www.lgim.com/ie/
 

Eszközök

Részvények
 
99,85%
Készpénz
 
0,12%
Egyéb
 
0,03%

Országok

Amerikai Egyesült Államok
 
78,45%
Svájc
 
5,47%
Hollandia
 
4,09%
Jersey
 
2,09%
Olaszország
 
1,96%
Németország
 
1,64%
Luxemburg
 
1,56%
Kanada
 
1,27%
Kína
 
1,23%
Egyesült Királyság
 
1,19%
Japán
 
0,90%
Készpénz
 
0,12%
Egyéb
 
0,03%

Ágazatok

Egészségügy
 
95,97%
IT/Telekommunikáció
 
2,65%
Fogyasztói javak
 
1,23%
Készpénz
 
0,12%
Egyéb
 
0,03%